Verified earnings results

Metagenomi Therapeutics Q3 2026 Earnings Results

Direct answer

Metagenomi Therapeutics reported Q3 2026 results on November 10, 2026.

Revenue was 2,184,000. EPS beat the estimate by 13.31%.
The result is verified against Verified earnings source.
Verified earnings source

Get free Metagenomi Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Earnings date
November 10, 2026
Reported timing
After the US market closes
EPS estimate
-0.646
Reported EPS
-0.56
Revenue
2,184,000
EPS surprise
EPS beat the estimate by 13.31%.

Read the frequently asked questions.

When did Metagenomi Therapeutics report Q3 2026 earnings?

Metagenomi Therapeutics reported on November 10, 2026. The reported timing was after the us market closes.

What is the available EPS estimate for Metagenomi Therapeutics?

The verified record provides an EPS estimate of -0.646.

Has Metagenomi Therapeutics reported the Q3 2026 result?

Revenue was 2,184,000. EPS beat the estimate by 13.31%.

Which source supports this Metagenomi Therapeutics earnings record?

The earnings record identifies Verified earnings source as its source. Missing values are not estimated.